Financial toxicity after robotic prostate cancer surgery: Younger patients at higher risk

Among men undergoing robot-assisted radical prostatectomy (RARP) for treatment of prostate cancer, younger patients are more likely to experience cancer-related financial toxicity, suggests a study in the Journal of Urology, an official journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.

This post was originally published on this site

Skip The Dishes Referral Code - Consult a Lawyer Online in a variety of legal subjects